isophane human insulin
isophane human insulin is a pharmaceutical drug with 7 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
NovoLet® Surveillance Study on Using Human Insulin System in Indonesia
Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes
Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 Diabetes
Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin
Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During "Real-life" Usage in Germany
Clinical Trials (7)
NovoLet® Surveillance Study on Using Human Insulin System in Indonesia
Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes
Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 Diabetes
Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin
Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During "Real-life" Usage in Germany
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin Degludec
Bioequivalence of Two Insulatard® Formulations in Healthy Subjects
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7